Simon Read

Director, Dianthus Therapeutics, Inc. /DE/

Bought, 12 months

$0.0M

Sold, 12 months

$0.6M

Companies

Latest trade

Aug 19, 2026

Companies

Dianthus Therapeutics, Inc. /DE/Director −$0.6M

Trades

DNTH Sold 2,778 shares at $117.55 · planned $0.3M Aug 19

DNTH Sold 2,777 shares at $109.55 · planned $0.3M Aug 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.